共同生活 发表于 2025-3-23 13:25:59

Ever-Evolving Disease Classification Criteria for Clinical Trials and Studies: The Case of Systemic ue patient, classification and classification criteria are used to describe populations for clinical trials and studies and to create somewhat homogeneous, reproducible, and understood populations for clinical research. The development of classification criteria with high sensitivity and specificity

字形刻痕 发表于 2025-3-23 16:05:05

http://reply.papertrans.cn/28/2706/270542/270542_12.png

FIS 发表于 2025-3-23 19:28:52

When the Illness Has No Name: Focus on Clinical Trials in Systemic Lupus Erythematosusrials, especially those with oversight by regulatory agencies, are pure, they are not. Systemic lupus erythematosus (SLE) clinical trials suffer from some of the same issues that plague everyday clinical life. Does everyone in a clinical trial truly have SLE? Is the activity score declared in the ca

Slit-Lamp 发表于 2025-3-23 22:32:15

http://reply.papertrans.cn/28/2706/270542/270542_14.png

nocturnal 发表于 2025-3-24 06:16:10

Managing and Tolerating Diagnostic Uncertaintyfor managing diagnostic uncertainty, however, this pursuit is inadequate. Diagnostic knowledge takes time to acquire, and diagnostic uncertainty is not completely curable. Furthermore, diagnostic uncertainty elicits negative psychological responses that need to be palliated, as well as positive resp

针叶类的树 发表于 2025-3-24 09:50:41

http://reply.papertrans.cn/28/2706/270542/270542_16.png

Carminative 发表于 2025-3-24 11:21:14

In the Box or Out of the Boxtudies in well-defined population. Inclusion and exclusion criteria may be the most important aspect of a clinical study or trial. Lumping or splitting determines which patients can ultimately use a risk stratification algorithm or a therapy. Both processes are valid; studies must be more transparent about how they have lumped or split.

抛弃的货物 发表于 2025-3-24 17:54:25

http://reply.papertrans.cn/28/2706/270542/270542_18.png

Ingredient 发表于 2025-3-24 21:32:47

http://reply.papertrans.cn/28/2706/270542/270542_19.png

空中 发表于 2025-3-25 02:09:14

http://reply.papertrans.cn/28/2706/270542/270542_20.png
页: 1 [2] 3 4 5 6
查看完整版本: Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202